Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
McKinney, 1995, Oesophageal and gastric cancer in Scotland 1960-90, Br J Cancer, 71, 411, 10.1038/bjc.1995.84
Hansson, 1993, Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden, Int J Cancer, 54, 402, 10.1002/ijc.2910540309
Hansson, 1993, Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985, Br J Surg, 80, 374, 10.1002/bjs.1800800338
Devesa, 1998, Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer, 83, 2049, 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2
Hansen, 1997, Esophageal and gastric carcinoma in Norway 1958-1992: incidence time trend variability according to morphological subtypes and organ subsites, Int J Cancer, 71, 340, 10.1002/(SICI)1097-0215(19970502)71:3<340::AID-IJC5>3.0.CO;2-Y
Lord, 1998, Rising incidence of oesophageal adenocarcinoma in men in Australia, J Gastroenterol Hepatol, 13, 356, 10.1111/j.1440-1746.1998.tb00646.x
Thomas, 1996, Incidence trends in oesophageal and proximal gastric carcinoma in Victoria, Aust N Z J Surg, 66, 271, 10.1111/j.1445-2197.1996.tb01183.x
Levi, 1991, Adenocarcinoma of the esophagus in Switzerland [letter; comment], JAMA, 265, 2960, 10.1001/jama.265.22.2960b
Yang, 1988, Incidence of cancer of the esophagus in the US by histologic type, Cancer, 61, 612, 10.1002/1097-0142(19880201)61:3<612::AID-CNCR2820610332>3.0.CO;2-Q
Pera, 1993, Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction, Gastroenterology, 104, 510, 10.1016/0016-5085(93)90420-H
Powell, 1990, Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites, Br J Cancer, 62, 440, 10.1038/bjc.1990.314
Blot, 1991, Rising incidence of adenocarcinoma of the esophagus and gastric cardia [see comments], JAMA, 265, 1287, 10.1001/jama.1991.03460100089030
Blot, 1993, Continuing climb in rates of esophageal adenocarcinoma: an update [letter], JAMA, 270, 1320, 10.1001/jama.1993.03510110056031
Daly, 1996, National Cancer Data Base report on esophageal carcinoma, Cancer, 78, 1820, 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z
Sampliner, 1998, Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology, Am J Gastroenterol, 93, 1028, 10.1111/j.1572-0241.1998.00362.x
Heath, 1994, Nonsteroidal anti-inflammatory drugs and human cancer. Report of an interdisciplinary research workshop, Cancer, 74, 2885, 10.1002/1097-0142(19941115)74:10<2885::AID-CNCR2820741023>3.0.CO;2-P
Vainio, 1997, NSAIDs, Barrett's oesophagus and adenocarcinoma prevention [letter], Eur J Cancer Prev, 6, 200
Giovannucci, 1994, Aspirin use and the risk for colorectal cancer and adenoma in male health professionals, Ann Intern Med, 121, 241, 10.7326/0003-4819-121-4-199408150-00001
IARC, 1997, Non-steroidal anti-inflammatory drugs, 1
Thun, 2002, Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues, J Natl Cancer Inst, 94, 252, 10.1093/jnci/94.4.252
Shaheen, 2002, Chemoprevention of gastrointestinal malignancies with nonsteroidal anti-inflammatory drugs, Cancer, 94, 950, 10.1002/cncr.10333
Gupta, 2001, Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2, Nat Rev Cancer, 1, 11, 10.1038/35094017
Ratnasinghe, 1999, Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey, Anticancer Res, 19, 171
Morris, 2001, Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia- adenocarcinoma sequence, Am J Gastroenterol, 96, 990
Shureiqi, 2001, Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression, Cancer Res, 61, 4879
el Attar, 1987, Prostaglandin synthesis by squamous carcinoma cells of head and neck, and its inhibition by non-steroidal anti-inflammatory drugs, J Oral Pathol, 16, 483, 10.1111/j.1600-0714.1987.tb00677.x
Fosslien, 2000, Molecular pathology of cyclooxygenase-2 in neoplasia, Ann Clin Lab Sci, 30, 3
Gallo, 2002, Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma, Hum Pathol, 33, 708, 10.1053/hupa.2002.125376
Kawabe, 2002, Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression, Oncology, 62, 46, 10.1159/000048246
Shirvani, 2000, Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure, Gastroenterology, 118, 487, 10.1016/S0016-5085(00)70254-X
Kandil, 2001, Cyclooxygenase-2 expression in Barrett's esophagus, Dig Dis Sci, 46, 785, 10.1023/A:1010700400960
Chang-Claude, 1990, An epidemiological study of precursor lesions of esophageal cancer among young persons in a high-risk population in Huixian, China, Cancer Res, 50, 2268
Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting, JAMA, 283, 2008, 10.1001/jama.283.15.2008
The Cochrane Controlled Trials Register. The Cochrane Library. Volume 4. Oxford: Update Software, updated quarterly, 2001.
Greenland, 1994, Invited commentary: a critical look at some popular meta-analytic methods, Am J Epidemiol, 140, 290, 10.1093/oxfordjournals.aje.a117248
Poole, 1999, Random-effects meta-analyses are not always conservative, Am J Epidemiol, 150, 469, 10.1093/oxfordjournals.aje.a010035
Petitti, 2000
DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2
Chow, 1998, Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia, J Natl Cancer Inst, 90, 150, 10.1093/jnci/90.2.150
Juni, 1999, The hazards of scoring the quality of clinical trials for meta-analysis, JAMA, 282, 1054, 10.1001/jama.282.11.1054
Juni, 2001, Systematic reviews in health care: assessing the quality of controlled clinical trials, BMJ, 323, 42, 10.1136/bmj.323.7303.42
Chalmers, 1983, Bias in treatment assignment in controlled clinical trials, N Engl J Med, 309, 1358, 10.1056/NEJM198312013092204
Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Controlled Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4
Schulz, 1995, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA, 273, 408, 10.1001/jama.1995.03520290060030
Schulz, 1994, Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals [see comments], JAMA, 272, 125, 10.1001/jama.1994.03520020051014
Imperiale, 1997, Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis, Ann Intern Med, 127, 1062, 10.7326/0003-4819-127-12-199712150-00002
Gerbarg, 1988, Resolving conflicting clinical trials: guidelines for meta-analysis, J Clin Epidemiol, 41, 503, 10.1016/0895-4356(88)90053-4
Imperiale, 1999, Meta-analysis: when and how, Hepatology, 29, 26S
Kleinbaum, 1982
Kendall, 1990
Garidou, 1996, Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population, Int J Cancer, 68, 295, 10.1002/(SICI)1097-0215(19961104)68:3<295::AID-IJC5>3.0.CO;2-X
Thun, 1993, Aspirin use and risk of fatal cancer, Cancer Res, 53, 1322
Suleiman, 2000, H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study, Eur J Cancer Prev, 9, 185, 10.1097/00008469-200006000-00006
Peleg, 1995, Nonsteroidal anti-inflammatory drugs (NSAID's) use and the risk of subsequent cancer of the upper gastrointestinal tract (UGI) [abstract], J Investig Med, 43, 251A
Langman, 2000, Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database, BMJ, 320, 1642, 10.1136/bmj.320.7250.1642
Funkhouser, 1995, Aspirin and reduced risk of esophageal carcinoma, Cancer, 76, 1116, 10.1002/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I
Coogan, 2000, Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel, Cancer Epidemiol Biomarkers Prev, 9, 119
Farrow, 1998, Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer, Cancer Epidemiol Biomarkers Prev, 7, 97
Cheng, 2000, A case-control study of oesophageal adenocarcinoma in women: a preventable disease, Br J Cancer, 83, 127, 10.1054/bjoc.2000.1121
Sharp, 2001, Risk factors for squamous cell carcinoma of the oesophagus in women: a case-control study, Br J Cancer, 85, 1667, 10.1054/bjoc.2001.2147
Sajadieh, 1999, Nonsteroidal anti-inflammatory drugs after acute myocardial infarction, Am J Cardiol, 83, 1263, 10.1016/S0002-9149(99)00068-5
Konstam, 2001, Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib, Circulation, 104, 2280, 10.1161/hc4401.100078
Jick, 2000, The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam, Pharmacotherapy, 20, 741, 10.1592/phco.20.9.741.35209
Garcia Rodriguez, 2000, Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women, Epidemiology, 11, 382, 10.1097/00001648-200007000-00004
Thun, 1991, Aspirin use and reduced risk of fatal colon cancer, N Engl J Med, 325, 1593, 10.1056/NEJM199112053252301
Pasricha, 1995, The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis, Gastroenterology, 109, 994, 10.1016/0016-5085(95)90411-5
Nugent, 1993, Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis, Br J Surg, 80, 1618, 10.1002/bjs.1800801244
Labayle, 1991, Sulindac causes regression of rectal polyps in familial adenomatous polyposis, Gastroenterology, 101, 635, 10.1016/0016-5085(91)90519-Q
Rubio, 1989, Effect of indomethacin in autotransplanted colonic tumors, Dis Colon Rectum, 32, 488, 10.1007/BF02554503
Rubio, 1986, Further studies on the therapeutic effect of indomethacin on esophageal tumors, Cancer, 58, 1029, 10.1002/1097-0142(19860901)58:5<1029::AID-CNCR2820580508>3.0.CO;2-D
Rubio, 1984, Antitumoral activity of indomethacin on experimental esophageal tumors, J Natl Cancer Inst, 72, 705
Tsibouris, 2001, NSAIDs do not protect patients with Barrett oesophagus from adenocarcinoma development (abstr), Gastroenterology, 120, A595, 10.1016/S0016-5085(08)82959-9
Schnell, 1997, Does aspirin (ASA) or NSAID use influence the development of esophageal adenocarcinoma (ADCA)?, Gastroenterology, 112, A652
Sample, 2002, Post-study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trial, Cancer Epidemiol Biomarkers Prev, 11, 281
Patterson, 1998, Cancer-related behavior of vitamin supplement users, Cancer Epidemiol Biomarkers Prev, 7, 79
Catella-Lawson, 2001, Cyclooxygenase inhibitors and the antiplatelet effects of aspirin, N Engl J Med, 345, 1809, 10.1056/NEJMoa003199
Blot, 1994, Esophageal cancer trends and risk factors, Semin Oncol, 21, 403
Blot, 1999, The changing epidemiology of esophageal cancer, Semin Oncol, 26, 2
Brown, 1994, Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors, Cancer Causes Control, 5, 333, 10.1007/BF01804984
Gammon, 1997, Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia [see comments], J Natl Cancer Inst, 89, 1277, 10.1093/jnci/89.17.1277
Lagergren, 1999, Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma, N Engl J Med, 340, 825, 10.1056/NEJM199903183401101
Shaheen, 2000, Is there publication bias in the reporting of cancer risk in Barrett's esophagus? [see comments], Gastroenterology, 119, 333, 10.1053/gast.2000.9302
Taylor, 1994, Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China, Cancer Res, 54, 2029s